Atlas Trials

SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type

Clinical trial NCT06775002 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06775002
Sponsor
Fuzhou General Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Lung Cancer, Non-Small CellLung Cancer Small Cell Lung Cancer (SCLC)
Start date
2026-04-05
Primary completion
2026-11-20
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.